BPCR
NEUTRALBioPharma Credit PLC Announces New $30 Million Investment
The specialist life sciences debt investment trust has entered into a senior secured loan agreement with Valneva Austria GmbH, investing $30 million.
BioPharma Credit
0.9200USD
-0.65%
Market Cap
1.04B
Volume
17.5k
1% of avg
P/E Ratio
NaN
EPS (TTM)
N/A
Beta
N/A
Day Range
0.9180p - 0.9300p
52 Week Range
0.8000p0.9200p0.9798p
0.9200p
Upcoming Events
BPCR
GOODBioPharma Credit Reports Strong Half-Year Performance with Increased Net Income
The investment company reported increased net income, substantial dividend coverage, and new commitments totaling $144.2 million. With a strong cash position and positive outlook, it's well-positioned for future growth.
BPCR
GOODBioPharma Credit PLC Provides $62.5 Million Financing to Precigen
The specialist life sciences debt investment trust is providing up to $62.5 million in financing to the commercial-stage biopharmaceutical company, supporting its growth and expansion plans.
BPCR
NEUTRALBioPharma Credit PLC Announces Half Year Results Date
The life sciences debt investor announces the date for its half year results release.
BPCR
NEUTRALBioPharma Credit PLC Announces Director/PDMR Shareholding
The company has announced a change in shareholding by a person closely associated with a director.
BPCR
NEUTRALBioPharma Credit PLC Appoints New Non-Executive Director
The healthcare investment trust has appointed a new non-executive director with extensive accounting and finance experience.
BPCR
NEUTRALBioPharma Credit PLC Announces Holding Change
The investment firm Adage Capital Management L.P. has disclosed a change in its shareholding in BioPharma Credit PLC.
BPCR
GOODBioCryst to Sell European ORLADEYO® Business for up to $264 Million
The pharmaceutical company has agreed to sell its European ORLADEYO® business for up to $264 million, allowing it to retire all remaining term debt.
BPCR
NEUTRALBioPharma Credit PLC Announces Holding Change
The investment company has disclosed a change in a major shareholder's holding.
BPCR
NEUTRALBioPharma Credit PLC Announces Director Appointment
The prominent investment company has announced the appointment of a new Non-Executive Director to its board.